Quest Diagnostics (NYSE:DGX) to go ex-dividend.
On 2/1/2018 Quest Diagnostics ( NYSE:DGX ) announced that it will be issuing a quarterly dividend in the amount of $0.50 down from  $0.50 making the yield 0.00472500472500473%.


Quest Diagnostics (NYSE:DGX) Ex- dividend date

Quest Diagnostics (NYSE:DGX) is set to go ex-dividend on and will be payable on 4/18/2018


Dividend History for Quest Diagnostics (NYSE:DGX)
The next payable dividend for Quest Diagnostics is scheduled for 4/18/2018. There is an annual dividend of $$1.80 with a yield of 1.73% The company’s dividend has increased by 11.70% on a 3 Year Average The payout ration for the trailing 12 months of earnings is 37.50% , 31.86% based on this years estimates and 29.51% based on next years projected estimates.

Recent Dividend History for Quest Diagnostics (NYSE:DGX)

• On 2/26/2013 Quest Diagnostics announced a quarterly dividend of $0.30.
• On 5/21/2013 Quest Diagnostics announced a quarterly dividend of $0.30.
• On 8/20/2013 Quest Diagnostics announced a quarterly dividend of $0.30.
• On 12/6/2013 Quest Diagnostics announced a quarterly dividend of $0.30.
• On 1/30/2014 Quest Diagnostics announced a quarterly dividend of $0.33.
• On 5/21/2014 Quest Diagnostics announced a quarterly dividend of $0.33.

Recent Insider Trading for Quest Diagnostics (NYSE:DGX)

• On 1/29/2018 Stephen H Rusckowski, Chairman, sold 106,840 with an average share price of $107.00 per share and the total transaction amounting to $11,431,880.00.
• On 1/24/2018 Catherine T Doherty, SVP, sold 21,294 with an average share price of $104.00 per share and the total transaction amounting to $2,214,576.00.
• On 1/2/2018 J. E Davis, EVP, sold 63,880 with an average share price of $98.68 per share and the total transaction amounting to $6,303,678.40.
• On 9/12/2017 Stephen H Rusckowski, Chairman, sold 59,235 with an average share price of $108.16 per share and the total transaction amounting to $6,406,857.60.
• On 9/11/2017 Daniel Stanzione, Director, sold 40,900 with an average share price of $108.07 per share and the total transaction amounting to $4,420,063.00.
• On 9/11/2017 Stephen H Rusckowski, CEO, sold 53,933 with an average share price of $108.16 per share and the total transaction amounting to $5,833,393.28.

Recent Analyst Rating for Quest Diagnostics (NYSE:DGX)

• On 1/29/2018 Goldman Sachs Group, Initiated Coverage, fromBuy to Buy to Buy with a price target of $117.00
• On 1/24/2018 Mizuho, Set Price Target, to bought with a price target of $113.00
• On 1/16/2018 Canaccord Genuity, Reiterated Rating, to bought with a price target of $110.00
• On 1/4/2018 Evercore ISI, Initiated Coverage, fromIn to In-Line to In with a price target of $103.00
• On 11/25/2017 Jefferies Group, Set Price Target, to Hold with a price target of $98.00
• On 10/27/2017 KeyCorp, Reiterated Rating, to Hold

Recent Trading for Quest Diagnostics (NYSE:DGX)
Shares of Quest Diagnostics closed the previous trading session at with 102.0009994506836 shares trading hands.